| UHC UMR Medical and Drug | Testosterone Replacement or Supplementation Therapy - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Transarterial Radioembolization (TARE)/ Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Transcatheter Procedures for Heart Valve Conditions - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Transcranial Magnetic Stimulation - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Upper Extremity Prosthetic Devices - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Ustekinumab - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Vertebral Body Tethering for Scoliosis - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Video Electroencephalographic (vEEG) Monitoring and Recording - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Visual Information Processing Evaluation and Orthoptic and Vision Therapy - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC UMR Medical and Drug | Vyjuvek® (Beramagene Geperpavec-Svdt) - Commercial Medical Benefit Drug Policy | 2026-01-01 |